| Financial Year |
March 31 2023 |
| Monetary Funds |
89,870,490.20 |
| Held-for-trading Financial Assets |
9,735,420.49 |
| Notes Receivable |
35,938,306.97 |
| Accounts Receivable |
204,713,156.14 |
| Advances to Suppliers |
1,167,920.19 |
| Other Receivables |
1,325,666.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
86,825,977.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,235,298.66 |
| Total Current Assets |
480,963,485.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,336,574.93 |
| Investment Properties |
21,161,526.51 |
| Fixed Assetes |
180,401,780.33 |
| Under-construction Projects |
161,719,549.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
85,121,176.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,619,351.53 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
361,658.67 |
| Sub-Total of Non-Current Assets |
481,985,565.00 |
| Total Assets |
962,949,050.37 |
| Short-Term Loans |
16,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
66,787,982.34 |
| Accounts Payable |
70,215,707.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,621,609.49 |
| Taxes Payable |
2,458,855.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
59,317,462.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,535,750.98 |
| Other Current Liabilities |
15,767,597.91 |
| Sub-Total of Current Liabilities |
249,971,896.75 |
| Long-term Loans |
27,721,248.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,165,049.43 |
| Total Liabilities |
285,136,946.18 |
| Paid-In Capital(Or Share Stock) |
157,781,250.00 |
| Capital Surplus |
344,055,634.15 |
| Surplus Reserve |
27,278,724.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
144,214,760.69 |
| Minority Stockholder's Interest |
4,481,734.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
673,330,369.28 |
| Owner's Equity（Stockholder's Equity） |
677,812,104.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
962,949,050.37 |
